A syngeneic anti tumor serum recognizing a complex H-2 alloantigen.

Area of Science:

• Immunology
• Oncology
• Transplantation Immunology

Background:

• Methylcholanthrene-induced tumors in BALB/c mice (H-2d) exhibit spontaneous regression upon transplantation into syngeneic hosts.
• This regression phenomenon is associated with the development of iso-antibodies possessing significant anti-tumor cytotoxic activity.

Purpose of the Study:

• To analyze the specificity of antibodies generated against a regressing methylcholanthrene-induced tumor (MCG4) in BALB/c mice.
• To investigate the relationship between tumor-associated antigens and host alloantigens, particularly H-2 antigens.

Main Methods:

• Induction and transplantation of a methylcholanthrene-induced tumor in BALB/c mice.
• Generation of iso-antibodies from BALB/c mice bearing the tumor.
• Specificity analysis of anti-tumor antibodies using cytotoxicity assays against tumor cells and various mouse strains, including B10.W congenic strains with wild-derived H-2wi haplotypes.

Main Results:

• BALB/c anti-MCG4 sera exhibited high anti-tumor cytotoxic activity.
• Antibody specificity analysis revealed reactivity against a tumor antigen closely resembling H-2 alloantigens, such as H-2.5, found on normal cells of foreign mouse strains.
• The sera cross-reacted with nine out of ten B10.W congenic strains carrying H-2wi haplotypes derived from wild mice.

Conclusions:

• The study identified a tumor antigen on a regressing BALB/c tumor that shares similarities with foreign H-2 alloantigens.
• The findings suggest a potential cross-reactivity between tumor-specific antigens and allogeneic histocompatibility antigens.
• Further investigation is required to determine if the tumor antigen is identical to or merely cross-reactive with foreign H-2 antigens.